🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is first-in-human phase 1/2 clinical trial to evaluate the safety, sys...
Status
Active Not Recruiting
Location
National Research Center - Institute of Immunology Federal Medical-Biological Agency
Start Date
2024-10-07
Trial ID
NCT07155499
Treatments Being Tested
Specific immunotherapy with recombinant birch pollen allergen rBet v1-FV...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2003-07
Trial ID
NCT00266526
Treatments Being Tested
More than 70% of birch pollen allergic patients suffer from allergic reacti...
Status
Completed
Location
Medical University of Vienna
Start Date
2012-03-14
Trial ID
NCT01449786
Treatments Being Tested
Safety and efficacy of recombinant birch pollen allergen in the treatment o...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2003-12
Trial ID
NCT00309062
Treatments Being Tested
To compare versus placebo the efficacy and safety of recombinant Bet v1, na...
Status
Terminated
Location
Pr Gabrielle PAULI
Start Date
2002-11
Trial ID
NCT00410930
Treatments Being Tested
Efficacy and Safety from a recombinant folding variant of Bet v 1...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2007-09
Trial ID
NCT00554983
Treatments Being Tested
This trial is performed for the immunological and histological evaluation o...
Status
Completed
Location
Prof. Dr. med. Sabina Rak
Start Date
2007-12
Trial ID
NCT00841516
Treatments Being Tested